Bloomfield, New Jersey Clinical Trials

A listing of Bloomfield, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 50 clinical trials
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

CALAVI US will investigate the safety, efficacy and pharmacokinetics of acalabrutinib together with Best Supportive Care in the treatment of COVID-19.

SARS
acalabrutinib
acute respiratory syndrome (sars)
oximetry
pneumonia
Research Site
 (9.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia (ATLAS-NEO)

This is a multicenter, multinational, open-label, one-way cross-over, Phase 3, single-arm study for treatment of hemophilia. The purpose of this study is to measure the frequency of treated bleeding episodes with fitusiran in male adult and adolescent (≥12 years old) participants with hemophilia A or B, with or without inhibitory …

Hackensack University Site Number : 8400009
 (9.4 away) Contact site
  • 0 views
  • 24 May, 2024
  • +53 other locations
NA-831 Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.

SARS
combination therapy
intrauterine device (iud)
dexamethasone
mechanical ventilation
Coronavirus Research Institute-Testing Site
 (4.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +29 other locations
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

haemophilia a
antihemophilic factor
factor ix
severe haemophilia a
hemophilia
Investigational Site Number 8400008
 (9.4 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +10 other locations
Yoga for Anxiety in Adults

The purpose of this study is to investigate the effect of a telerehabilitation-yoga intervention delivered remotely via videoconferencing on adults with Parkinson's Disease and anxiety symptoms.

anxiety
anxiety symptoms
Rutgers University
 (2.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

This phase II trial compares high-dose rate brachytherapy and stereotactic ablative radiotherapy as monotherapy in treating patients with prostate cancer that has not spread to other parts of the body (localized). High-dose rate brachytherapy delivers radiation directly into the prostate within a few minutes by a single radioactive seed through …

ct scan
alpha blocker
stage ii prostate cancer
transrectal ultrasound
prostate-specific antigen
Rutgers New Jersey Medical School
 (5.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

This is a Phase 2, randomized, multicenter, double-blind study of the glutaminase inhibitor telaglenastat with standard-of-care pembrolizumab and chemotherapy versus placebo with standard-of-care pembrolizumab and chemotherapy for first line treatment of metastatic disease in patients with KEAP1/NRF2-mutated, stage IV, nonsquamous, non-small cell lung cancer (NSCLC). The study primary endpoints are …

folic acid
proto-oncogene tyrosine-protein kinase ros
adjuvant
liquid biopsy
pembrolizumab
New Jersey Cancer Care and Blood Disorders (NJCCBD)
 (1.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +27 other locations
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

drug test
anaplastic lymphoma
lung cancer
pembrolizumab
stage iv non-small cell lung cancer
Hackensack Univ Med Ctr /ID# 216484
 (9.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +38 other locations
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer

This phase II trial studies how well TAS-102 and oxaliplatin work in treating patients with stage IV colon cancer. Drugs used in chemotherapy, such as TAS-102 and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or …

stage ivb colon cancer
colon cancer
adjuvant
stage iv colon cancer
ras mutation
Saint Barnabas Medical Center
 (7.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
Suicide Prevention for Patients With Chronic Pain

Patients with chronic pain and moderate suicide risk (n=60) will be randomized to receive remote-PST or remote-supportive psychotherapy. We will assess problem-solving deficits through self-report, objective neuropsychological assessment and caregiver report. We have used an adaptive design so that if there is strong evidence for target engagement, we will continue …

suicide
chronic widespread pain
amplified musculoskeletal pain syndrome
suicidal
psychotherapy
VA NJHCS
 (3.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location